# A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

> **NCT00800735** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 30 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Pegylated-interferon alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00800735
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800735, "A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00800735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*